UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders. (Q45297533)
Jump to navigation
Jump to search
scientific article published on 11 July 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders. |
scientific article published on 11 July 2005 |
Statements
UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders (English)
Javier Fernández-Ruiz
Ana Cabranes
Gareth Pryce
David Baker
José Antonio Ramos